Novel inexpensive ‘turn-on’ fluorescent biosensor for the sensitive detection of DNA damage induced by epirubicin

Abstract

For several decades, DNA has been well-known as the cellular target for various cytotoxic anticancer drugs. An active research area between chemistry, medicine and molecular biology is studying mechanism of interaction of drug molecules with DNA. In this study, we introduce a novel inexpensive and simple fluorescent biosensor to directly quantitate the DNA damage induced by epirubicin, an anticancer agent, and investigate the underlying molecular mechanisms of damage. The proposed fluorescent biosensor is established using terbium chloride. In damaged DNA, there are ssDNA regions facing the damaged nucleobases. In the damaged DNA, the terbium biosensor coordinates directly with the unpaired nucleobases accompanied by enhancement of its fluorescence, generating a measureable signal proportionate to the amount of damage. Moreover, dithiothreitol is used in this study to asses any possible DNA damage mechanisms that may occur other than the DNA oxidative damage that is commonly induced by various anthracyclines. In this work, the kinetics of the damage induced in DNA by epirubicin in absence and presence of dithiothreitol were compared using the proposed Tb3+ fluorescence biosensor. The results were confirmed using MALDI-TOF mass spectrometric analysis. It revealed that in absence of dithiothreitol, epirubicin induces oxidative DNA damage due to the interaction with reactive oxygen species causing strand breaks where the mass spectra show a significant reduction of the molecular-ion-peak of DNA, and appearance of peaks of smaller m/z indicating the DNA strand-breaks formation. While, in presence of dithiothreitol, epirubicin covalently binds to DNA to form DNA adducts with m/z values larger than the molecular-ion-peak of DNA target. Furthermore, the potency of epirubicin was examined on calf-thymus natural DNA samples with the proposed fluorescence biosensor. Whilst the interaction mechanism of epirubicin with DNA in presence of dithiothreitol shows slower DNA damage kinetics, but it has more potent damaging effect on DNA than in the case when no dithiothreitol is added. This introduces a novel alternative anticancer therapy that requires further investigation. Moreover, the low cost of the proposed fluorescent biosensor allows it to be an automatic simple process for the investigation of any DNA-drug interactions without the need to couple it with any other analytical method.